Autoimmune diseases Part 2: Disease modifying treatments and monitoring

Content developed by Dr Gerry Morrow MB ChB, MRCGP, Dip CBT

Medical Director Clarity Informatics and Editor, Clinical Knowledge Summaries

INTRODUCTION

In part 1, we described the signs and symptoms of, and investigations used to diagnose common autoimmune diseases. In part 2, we consider the function and effects of disease modifying treatments, a practical approach to shared monitoring and a referral strategy for those who may need specialist care.

LEARNING OUTCOMES

• Describe the two categories of disease modifying antirheumatic drugs
• Explain their mechanism of action
• List the potential adverse effects associated with these drugs
• Describe and undertake the appropriate monitoring of individuals taking these drugs
• Describe the circumstances when specialist services need to be contacted.

This resource is provided at an intermediate level. Read the article and answer the self-assessment questions, and reflect on what you have learned.

Complete the resource to obtain a certificate to include in your revalidation portfolio. You should record the time spent on this resource in your CPD log.